MANSFIELD, Mass., July 26 /PRNewswire/ -- Axeda Systems Inc. , the world's leading provider of device relationship management (DRM) software and services today announced, that the Olympus Diagnostic Systems Division, Life Science Group of Olympus Corporation, a precision technology leader in designing and delivering innovative solutions in healthcare and consumer electronics worldwide, (TYO: 7733), has licensed the Axeda DRM(TM) system for use on their AU(R) Series Chemistry-Immuno Analyzers.
The AU(R) series Chemistry-Immuno Analyzers were designed to provide greater efficiency for the high productivity demands of laboratories and hospitals. With Axeda DRM, instrument users will benefit from improved device uptime and performance, while Olympus will benefit from real-time access to critical instrument status and reportable information, enabling it to provide better customer service, faster and at lower costs.
"Device availability has always been crucial in the medical instrument industry, and Axeda DRM is rapidly gaining recognition as the most efficient, cost-effective method of remotely managing devices and reducing downtime," said Robert M. Russell Jr., chairman and chief executive officer of Axeda Systems. "The fact that increasing numbers of leading global medical instrument manufacturers like Olympus are choosing Axeda DRM is evidence that it is the solution of choice for the remote monitoring, management, and service of critical medical instruments worldwide."
The Axeda DRM system is a distributed software system that securely transmits status and usage data via the Internet from remote equipment to service representatives, alerting them if a device is operating outside preset performance standards. Axeda DRM leverages its patented Firewall-Friendly(TM) communications technology and existing network security within medical facilities. These and other features enable medical instrument companies to comply with regulations protecting patient information including 21 CFR Part 11 and HIPAA.
Olympus America Inc. will introduce its DRM branded solution to the U.S. market, at the AACC Annual Meeting in Los Angeles, CA July 25-29, 2004. Booth 701.
About Axeda(R)
The Company's flagship product, the Axeda DRM(TM) system helps manufacturing and service organizations increase revenue while lowering costs by proactively monitoring and managing devices deployed at customer sites around the world. Axeda(R) DRM(TM) is a highly scalable, field-proven, and comprehensive remote management solution that leverages its patented Firewall- Friendly(TM) technology to enable Machine-to-Machine (M2M) communication by utilizing the public Internet. Axeda customers include Global 2000 companies in many markets including Medical Instrument, Enterprise Technology, Office and Print Production Systems, and Industrial and Building Automation industries. Axeda has sales and service offices in the U.S., Europe, and Japan, and distribution partners worldwide. More information about Axeda is available at http://www.axeda.com/.
About Olympus Corporation
Olympus Corporation, with its wholly owned subsidiaries, is a global leader in designing, manufacturing and sales of equipment and devices for medical and healthcare, imaging and information and industrial applications. The company leverages R&D investment in technology and manufacturing processes across diverse business lines that include: digital cameras, film cameras, IC recorders, binoculars, medical endoscopes, endotherapy instruments, ultrasound endoscopes and accessories, biological microscopes, clinical analyzers, genome analysis system, information processing equipment, industrial videoscopes, industrial microscopes.
(C) 2004 Axeda Systems. All rights reserved. Axeda, Axeda Systems, Axeda DRM, Axeda Device Relationship Management System, Axeda Agents, Axeda Applications, Axeda Policy Manager, Axeda Enterprise, Axeda Access, Axeda Software Management, Axeda Service, Axeda Usage, Automatic eCommerce, Firewall-Friendly, and Access. Insight. In Real Time. are trademarks of Axeda Systems. All other trademarks are either property of Axeda Systems or property of their respective owners.
This press release may contain certain forward-looking statements that relate to Axeda's future performance. These forward-looking statements include, but are not limited to, those regarding Axeda's products and markets, and may include implied statements concerning market acceptance of Axeda's products and its growing leadership role in the DRM market. Such statements are subject to a number of risks and uncertainties that may cause the actual events or future results to differ from those discussed herein. Such factors include, among others: the difficulty of protecting and enforcing proprietary rights including but not limited to patent rights; the potential that Axeda may not be successful in enforcing its intellectual property rights; Axeda's ability to manage technological change and respond to evolving industry standards, including the potential that new technology not protected by Axeda's patent could be developed and patented by others; Axeda's customers' ability to implement or integrate Axeda's DRM solutions successfully and in a timely fashion or achieve benefits attributable to Axeda's DRM solutions; uncertainties in the market for DRM products and the potential for growth in the DRM market; the long sales cycle for DRM products; limited distribution channels; present and future competition; and Investors are advised to read Axeda's Annual Report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission, particularly those sections entitled "Factors Affecting Operating Results" and "Risk Factors" for a more complete discussion of these and other risks and uncertainties. Axeda assumes no obligation to update the forward-looking information contained in this press release.
Contact: Idalia Rodriguez Axeda Systems Inc. +1 (610) 407-7345 ir@axeda.com
CONTACT: Idalia Rodriguez, Axeda Systems Inc., +1-610-407-7345, ir@axeda.com
Web site: http://www.axeda.com/
No comments:
Post a Comment